![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, October 14, 2014 4:31:47 PM
- Announcement of final test protocol for HemaXellerate safety tests with timeline as to beginning, end, assessment before filing results with FDA as well as with whom the GLP tests will take place.
- FDA feedback on recent dCellVax IND with clarity as to issues and timeline for company response, if necessary (especially clarity as to whether or not further tests are needed and their expected timeframe)
- PR progress report on HemaX safety tests around mid-way point.
- PRs immediately upon any clinical trial approvals when they occur.
If results are positive, such PRs should create momentum and gather further interest. If news is negative, then only fair to communicate such with us investors.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM